On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
The U.S. Food and Drug Administration on Friday changed the label for the emergency contraception known as Plan B One-Step to make clear that the pill does not alter the course of an existing pregnancy.
The highly-contagious Omicron subvariant XBB has surged to more than 50% of COVID-19 cases in the northeastern United States and risks spreading fast as millions of Americans begin holiday travel on Friday.
The U.S. Food and Drug Administration (FDA) has approved Acer Therapeutics Inc's drug for treating patients with a type of genetic disorder called urea cycle disorders (UCDs), according to the health regulator's website.
An influential drug pricing research group said Eisai Co Ltd and Biogen Inc's new Alzheimer's disease treatment lecanemab should be priced lower than the drug Aduhelm that was developed by the companies.
Nearly 37 million people in China may have been infected with COVID-19 on a single day this week, Bloomberg News reported on Friday, citing estimates from the government's top health authority.
India is planning to make a COVID-19 negative test report mandatory for passengers arriving from countries with a high number of cases, the country's health minister said during an interview with broadcaster NewsX on Friday.
China's domestic production of medical supplies is expanding and is generally sufficient, a spokesperson for the Chinese foreign ministry said on Friday.
BioNTech and its partner for China, Shanghai Fosun Pharmaceutical , were granted approval for their COVID-19 vaccine that is adapted for the BA.4 and the BA.5 subvariants of Omicron for people aged 12 and older in Hong Kong, the German company said on Friday.
